阿托伐他汀对卒中后轻度认知功能障碍、神经功能恢复及脑血管储备能力的影响

doi:10.3969/j.issn.1000-8535.2022.04.005

广州医药 ›› 2022, Vol. 53 ›› Issue (4): 18-21.DOI: 10.3969/j.issn.1000-8535.2022.04.005

阿托伐他汀对卒中后轻度认知功能障碍、神经功能恢复及脑血管储备能力的影响

许璇, 余科, 祁风

广州市荔湾中心医院神经内科(广州 510000)

收稿日期:2021-10-22 出版日期:2022-07-20 发布日期:2022-08-03
通讯作者: 许璇,E-mail:269974125@qq.com
基金资助:
广东省医学科研基金(A2021285);广州市卫生健康科技项目(20191A010065)

Effects of atorvastatin on mild cognitive impairment, neurological recovery and cerebrovascular reserve capacity after stroke

XU Xuan, YU Ke, QI Feng

Department of Neurology,Liwan Central Hospital of Guangzhou,Guangzhou 510000,China

Received:2021-10-22 Online:2022-07-20 Published:2022-08-03

摘要/Abstract

摘要： 目的探讨不同剂量阿托伐他汀治疗能否作用于脑血管储备能力机制,进而影响卒中后轻度认知功能障碍患者的认知功能水平及神经功能。方法纳入2018年5月—2020年5月期间,在本院神经内科住院的100例卒中后轻度认知障碍患者。随机分为大剂量(阿托伐他汀40 mg/d)组和小剂量(阿托伐他汀10 mg/d)组。记录半年后的简易精神状态量表(MMSE)评分、神经功能评分(NIHSS)和脑血管储备能力。结果大剂量组的MMSE评分、NIHSS评分优于小剂量组,大剂量组的脑血管储备能力改善明显,2组之间有统计学差异。脑血管储备能力提高与认知功能改善有相关性。结论大剂量阿托伐他汀治疗可明显改善卒中后轻度认知功能障碍患者的脑血管储备能力,并促进患者认知功能及神经功能恢复。

关键词: 阿托伐他汀, 卒中, 轻度认知功能障碍, 脑血管储备能力

Abstract: Objective To investigate whether different doses of atorvastatin can contribute to the mechanism of cerebrovascular reserve capacity, and then affect the level of cognitive function and neurological function in patients with mild cognitive impairment after stroke. Methods A total of 100 patients with mild cognitive impairment after stroke hospitalized in the department of neurology from May 2018 to May 2020 were recorded. They were randomly divided into high-dose (atorvastatin 40 mg/d) group and low-dose (atorvastatin 10 mg/d) group. The Mini-Mental State Examination (MMSE), National Institute of Health Stroke Scale (NIHSS) and cerebrovascular reserve capacity were recorded half a year later. Results The scores of MMSE and NIHSS in the high-dose group were higher than those in the low-dose group. The cerebrovascular reserve capacity of the high-dose group was significantly improved, and there was significant difference between the two groups. There was a correlation between the improvement of cerebrovascular reserve capacity and cognitive function. Conclusions High dose of atorvastatin could significantly improve the cerebrovascular reserve capacity of patients with mild cognitive impairment after stroke, and promote the recovery of cognitive function and neurological function.

Key words: atorvastatin, stroke, mild cognitive impairment, cerebrovascular reserve capacity

许璇, 余科, 祁风. 阿托伐他汀对卒中后轻度认知功能障碍、神经功能恢复及脑血管储备能力的影响[J]. 广州医药, 2022, 53(4): 18-21.

XU Xuan, YU Ke, QI Feng. Effects of atorvastatin on mild cognitive impairment, neurological recovery and cerebrovascular reserve capacity after stroke[J]. Guangzhou Medical Journal, 2022, 53(4): 18-21.

参考文献

[1] 任庆国, 梁兵, 孟祥水. 血管性认知障碍临床诊断标准概述[J]. 实用医学杂志,2019,35(1): 1-3.
[2] 彭富, 黄载文, 梁耀武. 阿托伐他汀对不同阶段血管性认知功能障碍患者血脂和认知功能的影响[J]. 实用临床医药杂志,2016,20(9): 29-31,40.
[3] 贾琳琳. 阿托伐他汀钙片治疗卒中后认知功能障碍患者的综合疗效[J]. 中国药物经济学,2015(12): 73-75.
[4] MCGUINNESS B, CRAIG D, BULLOCK R, et al. Statins for the treatment of dementia[J]. Cochrane Database Syst Rev,2014(7): CD007514.
[5] MCGUINNESS B, CRAIG D, BULLOCK R, et al. Statins for the prevention of dementia[J]. Cochrane Database Syst Rev, 2016(1):CD003160.
[6] BARTHOLD D, JOYCE G, DIAZ BRINTON R, et al. Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk[J]. PLoS One,2020,15(3): e0229541.
[7] ZHOU D, LIU H, LI C, et al. Atorvastatin ameliorates cognitive impairment, Aβ1-42 production and Tau hyperphosphorylation in APP/PS1 transgenic mice[J]. Metab Brain Dis,2016,31(3): 693-703.
[8] FRACASSI A, MARANGONI M, ROSSO P, et al. Statins and the brain: more than lipid lowering agents?[J]. Curr Neuropharmacol, 2019,17(1):59-83.
[9] SEGATTO M, MANDUCA A, LECIS C, et al. Simvastatin treatment highlights a new role for the isoprenoid/cholesterol biosynthetic pathway in the modulation of emotional reactivity and cognitive performance in rats[J]. Neuropsychopharmacology, 2014,39(4):841-54.
[10] TONG X K, LECRUX C, ROSA-NETO P, et al. Age-dependent rescue by simvastatin of Alzheimer's disease cerebrovascular and memory deficits[J]. J Neurosci, 2012,32(14):4705-4715.
[11] 刘首明,江小萍,沈祖泓,等.可溶性CD40配体和炎症因子水平表达在颈动脉粥样硬化患者的应用[J].现代医院,2021,21(5):803-806.

[1]	唐梁, 陈志宁, 梁伟海, 刘晓俊, 欧阳樱君. 靳三针联合多奈哌齐治疗卒中后认知障碍的研究观察[J]. 广州医药, 2022, 53(2): 23-26.
[2]	朱颖洁, 谭少娟, 周远远, 朱利丹, 易招娣, 唐楚璇. 基于NNN-链接延续护理模式对脑卒中患者的影响[J]. 广州医药, 2022, 53(2): 102-107.
[3]	陈浩博, 李泽, 龙信聪, 谭三智, 胡蓉, 杨勇, 许婷, 李曼, 欧阳登, 周卓晟, 曹杰. 基于(1+1+N)紧密型医联体模式下的广州市白云区卒中防治[J]. 广州医药, 2022, 53(1): 96-100.
[4]	陶豫东. 益生菌结合肠内营养干预纠正缺血性急性脑卒中患者肠道菌落紊乱的作用及对其预后的影响[J]. 广州医药, 2022, 53(1): 109-113.
[5]	张琼, 黄淡銮, 尹玉珊. 大黄穴位贴联合直肠指力刺激治疗卒中后便秘的效果研究[J]. 广州医药, 2021, 52(6): 6-9.
[6]	陈钰杰. 四通道FES对脑卒中患者下肢运动功能影响的随机对照研究[J]. 广州医药, 2021, 52(6): 97-100.
[7]	周艳伟, 邓竹君, 谷丽颍, 张倩, 高晓凤. 延续性健康指导联合预见性干预对慢性脑卒中患者脑功能影响[J]. 广州医药, 2021, 52(4): 96-99.
[8]	陈冬妮, 吴维涛, 肖小华, 肖孝勇, 曾鸣, 崔曼丽, 杜新. 老年急性缺血性脑卒中并发肺部感染的危险因素[J]. 广州医药, 2021, 52(3): 28-31.
[9]	洪盈盈, 薛开禄, 肖鹏, 潘小华, 薛超. 低频电刺激治疗对脑卒中偏瘫患者周围神经电生理学与形态学的作用研究[J]. 广州医药, 2021, 52(2): 1-5.
[10]	陈丽萍, 韩棉梅, 傅思媚. 电针联合重复经颅磁刺激治疗脑卒中后抑郁伴失眠的临床研究[J]. 广州医药, 2021, 52(2): 6-10.
[11]	王俊奇, 顿驭光. 复方丹参滴丸联合阿托伐他汀治疗对伴有颈动脉粥样硬化短暂性脑缺血发作患者脑循环动力的影响[J]. 广州医药, 2021, 52(1): 105-108.
[12]	陈敏军, 徐刚, 高尊礼, 陈婉昭. 词联导航训练法结合针灸、环喉按摩对脑卒中构音功能障碍的疗效研究[J]. 广州医药, 2021, 52(1): 112-115.
[13]	宗寿健, 孙贵芝, 胡晓洁, 于丽红, 王学斌, 张金明, 王兴臣. 清化血浊中药对LAA型缺血性脑卒中的干预研究[J]. 广州医药, 2021, 52(1): 120-122.
[14]	陈丽萍, 傅思媚, 古智文, 潘集阳. 高频重复经颅磁刺激治疗卒中后抑郁伴失眠的临床研究[J]. 广州医药, 2020, 51(6): 28-32.
[15]	梁健欣, 黄华锰, 胡键浠, 李武英. 首发TIA/缺血性轻型卒中患者认知功能损害的状况分析[J]. 广州医药, 2020, 51(5): 50-54.

阿托伐他汀对卒中后轻度认知功能障碍、神经功能恢复及脑血管储备能力的影响

Effects of atorvastatin on mild cognitive impairment, neurological recovery and cerebrovascular reserve capacity after stroke

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价